Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good | Human Genomics | Full Text

Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good | Human Genomics | Full Text

Featured article: Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good

The field of pharmacogenomics is gradually shifting from the reactive testing of single genes toward the proactive testing of multiple genes to improve treatment outcomes, reduce adverse events, and decrease the burden of unnecessary costs for healthcare systems. Despite the progress in the field of pharmacogenomics, its implementation into routine care has been slow due to several barriers. This review focuses on some of the challenges faced by these initiatives, the solutions and different approaches for testing that they suggest, and the evidence that they provide regarding the benefits of preemptive pharmacogenomics testing.